References
1. Russell RJ, Brightling C.
Pathogenesis of asthma: implications for precision medicine. Clin Sci
(Lond) 2017;131:1723-1735.
2. Cockcroft DW, Davis BE, Blais CM.
Comparison of methacholine and mannitol challenges: importance of method
of methacholine inhalation. Allergy Asthma Clin Immunol 2020;16:14.
3. Cockcroft DW, Davis BE, Blais CM.
Direct bronchoprovocation test methods: history 1945-2018. Expert Rev
Respir Med 2019;13:279-289.
4. Lévesque V, Poirier C, Dubé BP.
Dose omission to shorten methacholine challenge testing: clinical
consequences of the use of a 10% fall in FEV(1) threshold. Allergy
Asthma Clin Immunol 2018;14:88.
5. Asher M, Keil U, Anderson H,
Beasley R, Crane J, Martinez F, et al. International Study of Asthma and
Allergies in Childhood (ISAAC): rationale and methods. Eur Respir J
1995;8:483-491.
6. Duhme H, Weiland SK, Rudolph P,
Wienke A, Kramer A, Keil U. Asthma and allergies among children in West
and East Germany: a comparison between Munster and Greifswald using the
ISAAC phase I protocol. International Study of Asthma and Allergies in
Childhood. Eur Respir J 1998;11:840-847.
7. Yavuz ST, Civelek E, Tuncer A,
Sahiner UM, Sekerel BE. Predictive factors for airway
hyperresponsiveness in children with respiratory symptoms. Ann Allergy
Asthma Immunol 2011;106:365-370.
8. Brand PL, Baraldi E, Bisgaard H,
Boner AL, Castro-Rodriguez JA, Custovic A, et al. Definition, assessment
and treatment of wheezing disorders in preschool children: an
evidence-based approach. Eur Respir J 2008;32:1096-1110.
9. Graham BL, Steenbruggen I, Miller
MR, Barjaktarevic IZ, Cooper BG, Hall GL, et al. Standardization of
Spirometry 2019 Update. An Official American Thoracic Society and
European Respiratory Society Technical Statement. Am J Respir Crit Care
Med 2019;200:e70-e88.
10. Merget R, Jörres RA, Heinze E,
Haufs MG, Taeger D, Brüning T. Development of a 1-concentration-4-step
dosimeter protocol for methacholine testing. Respir Med
2009;103:607-613.
11. Sterk PJ, Fabbri LM, Quanjer PH,
Cockcroft DW, O’Byrne PM, Anderson SD, et al. Airway responsiveness.
Standardized challenge testing with pharmacological, physical and
sensitizing stimuli in adults. Report Working Party Standardization of
Lung Function Tests, European Community for Steel and Coal. Official
Statement of the European Respiratory Society. Eur Respir J Suppl
1993;16:53-83.
12. Park JS, Choi YJ, Suh DI, Jung S,
Kim YH, Lee SY, et al. Profiles and characteristics of bronchial
responsiveness in general 7-year-old children. Pediatr Pulmonol
2019;54:713-720.
13. Tham EH, Lee AJ, Bever HV.
Aeroallergen sensitization and allergic disease phenotypes in Asia.
Asian Pac J Allergy Immunol 2016;34:181-189.
14. Lee E, Kim YH, Cho HJ, Yoon J,
Jung S, Yang SI, et al. Clinical phenotypes of bronchial
hyperresponsiveness in school-aged children. Ann Allergy Asthma Immunol
2018;121:434-443 e432.
15. Jo EJ, Eom JS, Mok J, Kim MH, Lee
K, Kim KU, et al. Patterns of sensitization to aeroallergens and their
effect on airway hyper-responsiveness in Busan, Korea. Asian Pac J
Allergy Immunol 2019 Jul 16. doi: 10.12932/AP-261118-0447.
16. Vincent M, Corazza F, Chasseur C,
Bladt S, Romano M, Huygen K, et al. Relationship between mold exposure,
specific IgE sensitization, and clinical asthma: A case-control study.
Ann Allergy Asthma Immunol 2018;121:333-339.
17. Mosges R, Graute V, Christ H,
Sieber HJ, Wahn U, Niggemann B. Safety of ultra-rush titration of
sublingual immunotherapy in asthmatic children with tree-pollen allergy.
Pediatr Allergy Immunol 2010;21:1135-1138.
18. Lee J, Song JU. Diagnostic
comparison of methacholine and mannitol bronchial challenge tests for
identifying bronchial hyperresponsiveness in asthma: a systematic review
and meta-analysis. J Asthma 2020 Mar
16;1-9. doi: 10.1080/02770903.2020.1739704.
19. Jung S, Suh DI, Lee SY, Yoon J, Cho HJ, Kim YH, et al. Prevalence,
Risk Factors and Cutoff Values for Bronchial Hyperresponsiveness to
Provocholine in 7-Year-Old Children. Allergy Asthma Immunol Res
2018;10:466-477.
20. Fuchs O, Bahmer T, Rabe KF, von
Mutius E. Asthma transition from childhood into adulthood. Lancet Respir
Med 2017;5:224-234.
21. Gray L, Peat JK, Belousova E,
Xuan W, Woolcock AJ. Family patterns of asthma, atopy and airway
hyperresponsiveness: an epidemiological study. Clin Exp Allergy
2000;30:393-399.
22. Alharbi SA, Kobeisy SAN, AlKhater
SA, Alharbi AS, Alqwaiee MM, Alotaibi FN, et al. Childhood Asthma
Awareness in Saudi Arabia: Five-Year Follow-Up Study. J Asthma Allergy
2020;13:399-407.
23. Ciprandi G, Marseglia GL,
Ricciardolo FLM, Tosca MA. Pragmatic Markers in the Management of
Asthma: A Real-World-Based Approach. Children (Basel) 2020;7:48.
24. Castro-Rodriguez JA, Cifuentes L,
Martinez FD. Predicting Asthma Using Clinical Indexes. Front Pediatr
2019;7:320.
25. Jackson DJ, Gern JE, Lemanske RF,
Jr. Lessons learned from birth cohort studies conducted in diverse
environments. J Allergy Clin Immunol 2017;139:379-386.
26. de Marco R, Marcon A, Jarvis D,
Accordini S, Almar E, Bugiani M, et al. Prognostic factors of asthma
severity: a 9-year international prospective cohort study. J Allergy
Clin Immunol 2006;117:1249-1256.
27. Rassouli F, Tinschert P, Barata
F, Steurer-Stey C, Fleisch E, Puhan MA, et al. Characteristics of
Asthma-related Nocturnal Cough: A Potential New Digital Biomarker. J
Asthma Allergy 2020;13:649-657.
28. Fukuhara A, Saito J, Birring SS,
Sato S, Uematsu M, Suzuki Y, et al. Clinical Characteristics of Cough
Frequency Patterns in Patients with and without Asthma. J Allergy Clin
Immunol Pract 2020;8:654-661.
29. Ohwada A, Sato K. Heterogeneity
of perception of symptoms in patients with asthma. J Thorac Dis
2019;11:5218-5227.
30. Francisco B, Ner Z, Ge B, Hewett
J, König P. Sensitivity of different spirometric tests for detecting
airway obstruction in childhood asthma. J Asthma 2015;52:505-511.
31. Ciprandi G, Gallo F, Cirillo I.
FEF25-75 and Asthma in Clinical Practice. Iran J Allergy Asthma Immunol
2018;17:295-297.
32. Malerba M, Radaeli A, Olivini A,
Damiani G, Ragnoli B, Sorbello V, et al. Association of FEF25-75%
Impairment with Bronchial Hyperresponsiveness and Airway Inflammation in
Subjects with Asthma-Like Symptoms. Respiration 2016;91:206-214.
33. Hardaker KM, Downie SR, Kermode
JA, Farah CS, Brown NJ, Berend N, et al. Predictors of airway
hyperresponsiveness differ between old and young patients with asthma.
Chest 2011;139:1395-1401.
34. Harmanci K, Bakirtas A, Turktas
I. Factors affecting bronchial hyperreactivity in asthmatic children. J
Asthma 2008;45:730-734.
35. Lukic KZ, Coates AL. Does the
FEF25-75 or the FEF75 have any value in assessing lung disease in
children with cystic fibrosis or asthma? Pediatr Pulmonol
2015;50:863-868.
36. Quanjer PH, Weiner DJ, Pretto JJ,
Brazzale DJ, Boros PW. Measurement of FEF25-75% and FEF75% does not
contribute to clinical decision making. Eur Respir J 2014;43:1051-1058.
37. Kim YH, Lee E, Cho HJ, Yang SI,
Jung YH, Kim HY, et al. Association between menarche and increased
bronchial hyper-responsiveness during puberty in female children and
adolescents. Pediatr Pulmonol 2016;51:1040-1047.
38. Grönke L, Kanniess F, Holz O,
Jörres RA, Magnussen H. The relationship between airway
hyper-responsiveness, markers of inflammation and lung function depends
on the duration of the asthmatic disease. Clin Exp Allergy
2002;32:57-63.
39. Caudri D, Wijga A, CM AS,
Hoekstra M, Postma DS, Koppelman GH, et al. Predicting the long-term
prognosis of children with symptoms suggestive of asthma at preschool
age. J Allergy Clin Immunol 2009;124:903-910 e901-907.